Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2016

Aug 12, 2016

35081_dirs_2016-08-12_509b3ff0-1406-4db3-a1cd-b9ff580682ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tiger X Medical, Inc. (CDOM)
CIK: 0000925741
Period of Report: 2016-08-11

Reporting Person: LIU STEPHEN H (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-11 Common Stock A 75000 $0.00 Acquired 75000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 200000 Indirect
Common Stock 2600000 Indirect

Footnotes

F1: Pursuant to a Stock Award Agreement effective August 11, 2016 between Tiger X Medical, Inc. (the "Company") and the reporting person (the "Agreement"), this grant of restricted stock of the Company vests in full on August 11, 2017 (the "Vesting Date"), subject to the reporting person's continued service with the Company; provided, however, to the extent the reporting person's service with the Company is terminated for any reason within thirty (30) days prior to or upon a Change in Control (as defined in the Agreement) prior to the Vesting Date, this grant of restricted stock will immediately and automatically vest in full.

F2: The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest in such securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: The reporting person owns 35%, and serves as a director, of Marin Blue, Inc.